Scleroderma, Systemic Clinical Trial
— SScM398-1Official title:
A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis: a Randomized Controlled Trial
Background: A typical feature of SSc is the fibrotic involvement of the connectival tissue of
the face, which causes microstomia.
Objectives: To test the effectiveness of an educational intervention with "face to face"
training, compared to a standard information program, to reduce microstomia in women with
SSc.
Methods: SSc patients were randomized to the experimental and control group. Both groups
received written and audiovisual information for self-management of microstomia; in addition,
the experimental group received a reinforced training at baseline and at follow-up. Primary
outcome: change in inter-incisal distance; secondary outcome: patient-reported mouth
disability.
Status | Completed |
Enrollment | 39 |
Est. completion date | January 31, 2015 |
Est. primary completion date | January 31, 2015 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - diagnosis of SSc, according to the ACR/EULAR criteria; - age >18 years; - ability to understand the Italian language; - subjective perception of problems with opening the mouth, such as hardened tissues, reduced mobility, pain - confirmed by a dermatologist; - signed informed consent. Exclusion Criteria: - edentulous patients, - presence of dental conditions, - documented dysfunction of the temporo-mandibular joint, - oral neoplasia, - sub-mandibular inflammatory conditions, - patients already undergoing face massages or face physiotherapy, - patients who had undergone mouth lipofilling, - patients with severe hand disability (including deep ulcers, and severe pain), - patients with documented psychiatric conditions or taking psychotropic medications. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti | Centro di Eccellenza per la Cultura e la Ricerca Infermieristica (CECRI), Ministry of Health, Italy |
Ayala F, de Baranda Andújar PS. Effect of 3 different active stretch durations on hip flexion range of motion. J Strength Cond Res. 2010 Feb;24(2):430-6. doi: 10.1519/JSC.0b013e3181c0674f. — View Citation
Kroon FP, van der Burg LR, Buchbinder R, Osborne RH, Johnston RV, Pitt V. Self-management education programmes for osteoarthritis. Cochrane Database Syst Rev. 2014 Jan 15;(1):CD008963. doi: 10.1002/14651858.CD008963.pub2. Review. — View Citation
Lorig K. Partnerships between expert patients and physicians. Lancet. 2002 Mar 9;359(9309):814-5. — View Citation
Maddali Bongi S, Del Rosso A, Miniati I, Galluccio F, Landi G, Tai G, Matucci-Cerinic M. The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients. Rheumatol Int. 2012 Sep;32(9):2785-90. doi: 10.1007/s00296-011-2049-x. Epub 2011 Aug 17. — View Citation
Naylor WP, Douglass CW, Mix E. The nonsurgical treatment of microstomia in scleroderma: a pilot study. Oral Surg Oral Med Oral Pathol. 1984 May;57(5):508-11. — View Citation
Synnot A, Ryan R, Prictor M, Fetherstonhaugh D, Parker B. Audio-visual presentation of information for informed consent for participation in clinical trials. Cochrane Database Syst Rev. 2014 May 9;(5):CD003717. doi: 10.1002/14651858.CD003717.pub3. Review. — View Citation
Uras C, Giannantoni P, Tabolli S, DI Giulio P, Peghetti A, Cianchini G, Abeni D. Measuring disability of women with systemic sclerosis: validation of the italian version of the systemic sclerosis questionnaire. G Ital Dermatol Venereol. 2016 Aug;151(4):332-9. Epub 2015 May 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Interincisal distance | Change in the maximum distance between the tip of the upper and lower incisors, from baseline to 1-year follow-up. | 1 year | |
Secondary | Self-reported severity of mouth disability | To measure mouth disability, the investigators used the Italian version of the standardized self-administered questionnaire Mouth Handicap in Systemic Sclerosis (MHISS). MHISS consists of 12 items (each scored 0-4, with a total score ranging from 0 to 48) divided into 3 subscales: subscale 1 (5 items: 1, 3, 4, 5 and 6; range 0-20) examines handicap related to reduced mouth opening; subscale 2 (5 items: 2, 7, 8, 9 and 10; range 0-20) assesses handicap related to sicca syndrome; and subscale 3 (items 11 and 12; range 0-8) examines aesthetic concerns. The total score is obtained by summing the score for all items. Higher scores denote a greater mouth disability. | 1 year | |
Secondary | Dermatological life quality | Quality of life was measured with the Skindex-17, a dermatology-specific questionnaire consisting of 17 items subdivided into two scales: Symptoms and Psychosocial. Possible range for both scales 0 - 100. Higher scores indicate a greater impact of the disease. Interpretation: for the Symptoms scale, <50 non-severe, >=50 severe; for the Psychosocial scale, <20.82 mild, 20.83-37.50 moderate, >=37.51 severe. | 1 year | |
Secondary | Disease-specific life quality | To measure disease-specific life quality the investigators used the Systemic Sclerosis Questionnaire (SySQ), a self-administered standardized questionnaire whose Italian version was validated in our institution. The SySQ has four scales: General Symptoms, 8 items; Muscle-Skeletal, 11 items; Cardio-Respiratory, 6 items; Gastro-Intestinal, 7 items. Items are all scored 0-3. Scale scores are given by the mean of the items belonging to that scale, again with range 0-3. Higher scores indicate a worse quality of life. | 1 year | |
Secondary | Psychological well-being | Possible presence of anxiety/depression was investigated with a generic questionnaire validated in the field of dermatology, the 12-item General Health Questionnaire-12 (GHQ-12). GHQ-12 items have 4 possible answers, and scores were computed in the conventional way, collapsing adjacent responses to obtain a dichotomous scoring (0 + 0 + 1 + 1). Possible score 0-12. Based on previous research, patients were classified as "GHQ-cases" (i.e., with probable minor non psychotic disorders) if the dichotomous scoring was >=4; and as "GHQ-noncases" if the dichotomous scoring was <4. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03965780 -
The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)
|
N/A | |
Terminated |
NCT02558543 -
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
|
Phase 2 | |
Withdrawn |
NCT01202045 -
Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
|
N/A | |
Terminated |
NCT01445821 -
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
|
Phase 3 | |
Recruiting |
NCT05878717 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
|
Phase 3 | |
Recruiting |
NCT03559465 -
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
|
N/A | |
Not yet recruiting |
NCT03610217 -
Pragmatic Clinical Trials in Scleroderma
|
N/A | |
Completed |
NCT02655640 -
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis
|
N/A | |
Completed |
NCT05622578 -
Phenotyping of Chronic Pain in Diffused Systemic Scleroderma
|
N/A | |
Recruiting |
NCT04804930 -
Trichoscopy and Systemic Scleroderma
|
||
Completed |
NCT03675581 -
A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
|
Phase 1 | |
Completed |
NCT03221257 -
Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate
|
Phase 2 | |
Recruiting |
NCT05559580 -
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
|
Phase 2 | |
Completed |
NCT00442611 -
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
|
Phase 1/Phase 2 | |
Completed |
NCT00001330 -
Study of Silicone-Associated Connective Tissue Diseases
|
N/A | |
Completed |
NCT02597933 -
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
|
Phase 3 | |
Not yet recruiting |
NCT05821335 -
Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis
|
N/A | |
Completed |
NCT00333437 -
Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
|
N/A | |
Completed |
NCT00025818 -
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
|
Phase 3 | |
Not yet recruiting |
NCT05351060 -
Novel Splinting Technique Using 3D Models
|
N/A |